[1]
|
Cai, Z. and Liu, Q. (2019) Understanding the Global Cancer Statistics 2018: Implications for Cancer Control. Science China Life Sciences. https://doi.org/10.1007/s11427-019-9816-1
|
[2]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[3]
|
Flocks, R.H., Urich, V.C., Patel, C.A., et al. (1960) Studies on the Antigenic Properties of Prostatic Tissue. International Journal of Urology, 84, 134-143. https://doi.org/10.1016/S0022-5347(17)65503-4
|
[4]
|
Vickers, A.J., Cronin, A.M., Roobol, M.J., et al. (2010) The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group. Clinical Cancer Research, 16, 4374-4381.
https://doi.org/10.1158/1078-0432.CCR-10-1328
|
[5]
|
Kim, S.H., Choi, M.S., Kim, M.J., et al. (2017) Validation of Prostate Imaging Reporting and Data System Version 2 Using an MRI-Ultrasound Fusion Biopsy in Prostate Cancer Diagnosis. American Journal of Roentgenology, 209, 800-805. https://doi.org/10.2214/AJR.16.17629
|
[6]
|
Barr, R.G., Cosgrove, D., Brock, M., et al. (2017) WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 5. Prostate. Ultrasound in Medicine and Biology, 43, 27-48.
https://doi.org/10.1016/j.ultrasmedbio.2016.06.020
|
[7]
|
张帆, 黄毅, 陆敏, 马潞林. 临床低危型前列腺癌根治性切除术后病理升级的危险因素分析[J]. 微创泌尿外科杂志, 2013, 2(4): 280-283.
|
[8]
|
Hodge, K.K., McNeal, J.E., Terris, M.K., et al. (1989) Random Systematic versus Directed Ultrasound-Guided Transrectal Core Biopsies of the Prostate. Journal d’Urologie, 142, 71-74. https://doi.org/10.1016/S0022-5347(17)38664-0
|
[9]
|
Gaylis, F., Nasseri, R., Fink, L., et al. (2016) Prostate Biopsy Complications: A Dual Analysis. Urology, 93, 135-140.
https://doi.org/10.1016/j.urology.2016.03.035
|
[10]
|
王炜, 李传刚, 刘辉, 等. 前列腺特异性抗原对前列腺癌诊断价值的探讨[J]. 中国医科大学学报, 2016, 45(1): 61-65+69.
|
[11]
|
魏强, 韩平. 前列腺特异性抗原与前列腺癌[J]. 临床外科杂志, 2006(2): 81-83.
|
[12]
|
Mannello, F. and Gazzanelli, G. (2001) Prostate-Specific Antigen (PSA/hK3): A Further Player in the Field of Breast Cancer Diagnostics? Breast Cancer Research, 3, 238-243. https://doi.org/10.1186/bcr302
|
[13]
|
Henley, S.J., Ward, E.M., Scott, S., et al. (2020) Annual Report to the Nation on the Status of Cancer, Part I: National Cancer Statistics. Cancer, 126, 2225-2249. https://doi.org/10.1002/cncr.32802
|
[14]
|
Xu, J. (2014) The Xu’s Chart for Prostate Biopsy: A Visual Presentation of the Added Value of Biomarkers to Prostate-Specific Antigen for Estimating Detection Rates of Prostate Cancer. Asian Journal of Andrology, 16, 536-540.
https://doi.org/10.4103/1008-682X.125907
|
[15]
|
韩苏军, 张思维, 陈万青, 等. 中国前列腺癌发病现状和流行趋势分析[J]. 鳞状肿瘤学杂志, 2013, 19(4): 330-334.
|
[16]
|
Chen, R., Xie, L., Cai, X., et al. (2015) Percent Free Prostate-Specific Antigen for Prostate Cancer Diagnosis in Chinese Men with a PSA of 4.0-10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium. Asian Journal of Urology, 2, 107-113. https://doi.org/10.1016/j.ajur.2015.04.022
|
[17]
|
Kandıralı, E., Temiz, M.Z., Çolakerol, A., et al. (2018) Does the Prostate Volume Always Effect Cancer Detection Rate in Prostate Biopsy? Additional Role of Prostate-Specific Antigen Levels: A Retrospective Analysis of 2079 Patients. Turkish Journal of Urology, 45, 103-107. https://doi.org/10.5152/tud.2018.66909
|
[18]
|
Tang, P., Du, W., Xie, K., et al. (2013) Transition Zone PSA Density Improves the Prostate Cancer Detection Rate Both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese Men. Urologic Oncology, 31, 744-748.
https://doi.org/10.1016/j.urolonc.2011.06.012
|
[19]
|
Chavan, P.R., Chavan, S.V., Chavan, N.R., et al. (2009) Detection Rate of Prostate Cancer Using Prostate Specific Antigen in Patients Presenting with Lower Urinary Tract Symptoms: A Retrospective Study. Journal of Postgraduate Medicine, 55, 17-21. https://doi.org/10.4103/0022-3859.43548
|
[20]
|
Yücel, C., Budak, S., Kısa, E., et al. (2018) The Sufficiency of 6 Core Sextant Prostate Biopsy in Patients with Prostate Specific Antigen (PSA) Values over 20 ng/ml. Archivio Italiano di Urologia e Andrologia, 90, 104-106.
https://doi.org/10.4081/aiua.2018.2.104
|
[21]
|
Kash, D.P., Lal, M., Hashmi, A.H., et al. (2014) Utility of Digital Rectal Examination, Serum Prostate Specific Antigen, and Transrectal Ultrasound in the Detection of Prostate Cancer: A Developing Country Perspective. Asian Pacific Journal of Cancer Prevention, 15, 3087-3091. https://doi.org/10.7314/APJCP.2014.15.7.3087
|
[22]
|
李昕, 张祥华, 张争, 等. 北京多中心社区50岁以上男性年龄与前列腺特异性抗原的关系[J]. 北京大学学报: 医学版, 2012, 44(2): 288-290.
|
[23]
|
王明珠, 高中伟, 贺大林, 等. 西安地区汉族成年健康男性年龄与血清前列腺特异性抗原的关系[J]. 中华医学杂志, 2003, 83(19): 1665-1667.
|
[24]
|
蔡凯, 刘志宇, 王梁, 等. 大连地区男性年龄相关前列腺特异性抗原参考值范围[J]. 中国医科大学学报, 2017, 46(10): 927-930.
|
[25]
|
王功伟, 沈丹华. 前列腺腺癌患者年龄与血清PSA相关性初步分析[J]. 现代泌尿生殖肿瘤杂志, 2014(3): 146-149.
|
[26]
|
赵佳, 王建华, 韩雪, 等. 前列腺癌患者特异性抗原的影响因素分析[J]. 健康教育与健康促进, 2015(6): 417-418.
|
[27]
|
李培军, 张祥华, 郭利君, 等. 血清PSA与良性前列腺增生临床病理的相关性研究[J]. 中华泌尿外科杂志, 2006, 27(6): 421-423.
|
[28]
|
Na, R., Wu, Y., Xu, J., et al. (2013) Age-Specific Prostate Specific Antigen Cutoffs for Guiding Biopsy Decision in Chinese Population. PLoS ONE, 8, e67585. https://doi.org/10.1371/journal.pone.0067585
|